Isomorphic Labs raises $5B, its second mega-round in six months
The Decoder · rss · 2026-11-17
Isomorphic Labs, Alphabet's AI drug discovery company led by Demis Hassabis, has raised $5 billion — just six months after a $2.1 billion round. The funding will push its drug pipeline toward clinical trials; the company has no approved drugs yet.
More from Venture
- Anthropic IPO filing reportedly reveals $900.9B in purchase and lease commitments through 2045 — Polymarket · 2026-11-17
- VC's 'Diffusion Gap' formula: lab revenue growth minus log-linear CapEx spend — saranormous · 2026-11-17
- Voyage Labs raises $12M for a specialized AI travel planning agent — TechCrunch AI · 2026-11-17
- HSBC dumps $300M of Oracle/OpenAI data center debt at steep mid-80s discount — GaryMarcus · 2026-11-17
- Isomorphic Labs closes $5B Series C to move drug candidates toward trials — TechCrunch AI · 2026-11-17
- Anthropic IPO allocation will disappoint sellers cashing out early, investor warns — firstadopter · 2026-11-17